Abba Medix Group Inc. Announces Closing of Private Placement

TORONTO, ONTARIO -- (Marketwired) -- 11/25/15 -- Abba Medix Group Inc. (the "Company") (CSE: ABA) is pleased to announce that it has closed a non-brokered private placement (the "Financing") of common shares. A total of 3,000,000 common shares were issued to an arm's length third-party at CDN$0.10 per common share for aggregate gross proceeds of CDN$300,000.

The net proceeds of the Financing will be used for general corporate purposes.

The Common Shares issued pursuant to the Financing are subject to a four-month hold period under applicable securities laws.

About Abba Medix Group Inc.

Abba Medix Group Inc. (CSE: ABA) is the parent company of Abba Medix Corp.; a company committed to becoming a purveyor of fine medical cannabis in Canada. In compliance with Health Canada's regulations, the company's goal is to become a marketplace leader through strategic partnerships, mergers, and acquisitions to create a fully integrated medical cannabis marketplace. Abba's mission is to find, acquire or create joint venture opportunities in patient focused medical cannabis related companies, products, organizational events, sponsorships, educational training, and research and development within medical cannabis sector. For more information please visit www.abbamedix.com.

Contacts:
Abba Medix Group Inc.
Ray Ahmad Rasouli
Chief Executive Officer
(905) 492-9420
www.abbamedix.com

Source: Abba Medix Group Inc.

You May Also Be Interested In

• Abasca Announces Filing of Technical Report Regarding Positive Preliminary Economic Assessment for the Loki Flake Graphite Deposit and Private Placement of $2.25 Million
• Elemental Royalty Corp (ELE) PT Lowered to $31 at H.C. Wainwright
• Abasca files PEA technical report for Loki graphite deposit in Saskatchewan